21 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, erectile dysfunction, male reproductive system disorder, physiological sexual disorder, psychiatric disorderNot yet recruitingPhase 32026-10-05NCT07859202
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 32026-10-01NCT06016842
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion StrokeCerebral Small Vessel Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingNot applicable2026-09-11NCT06649240
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKEEmbolism and Thrombosis, antiphospholipid syndrome, autoimmune disease, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, immune system disorder, ischemic stroke, nervous system disorder, stroke disorder, thrombotic disease, transient ischemic attack, vascular disorderActive, not recruitingPhase 42026-09-11NCT05995600
Transition of Care in Pediatric Rare Endocrine Disordersendocrine system disorderRecruitingNot applicable2026-08-25NCT07786142
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary DyspepsiaBiliary DyspepsiaRecruitingPhase 42026-07-29NCT07016269
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).Cholesterol CholelithiasisRecruitingPhase 42026-07-29NCT07005752
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve ReplacementVentricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart failure, heart valve disorderRecruitingPhase 42026-06-29NCT05672836
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total OcclusionsChronic Total Occlusion of Coronary ArteryRecruitingNot stated2026-06-25NCT03667196
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery DiseaseArterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingNot applicable2026-06-24NCT05829889
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 1 / Phase 22026-06-17NCT04036682
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery AtherosclerosisInfarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral infarction, cerebrovascular disorder, ischemic disease, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 42026-03-27NCT06757764
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorderActive, not recruitingPhase 22026-03-13NCT06256328
Drug-Coated Balloon in Patients With High Bleeding RiskArterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderActive, not recruitingNot applicable2026-02-12NCT05221931
AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICMbrain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingNot stated2026-01-16NCT07347691
Effects of the Health Promotion Program on Health Literacy, Physical and Mental Health Status, and Quality of LifeChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and SymptomsActive, not recruitingNot applicable2025-12-29NCT07306520
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitationcardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiencyActive, not recruitingPhase 32025-12-29NCT06027307
Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2cardiovascular disorder, coronary artery disorder, coronary stenosis, heart disorder, myocardial ischemia, vascular disorderRecruitingNot applicable2025-11-28NCT06742931
MIT-001 for Prevention of CCRT-Induced OM in HNSCC PatientsHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, mouth disorder, neoplasm, squamous cell carcinoma, stomatitisActive, not recruitingPhase 22025-04-06NCT04651634
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutationnon-small cell lung carcinomaActive, not recruitingNot stated2024-12-06NCT06247280
Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy VolunteersCOVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaActive, not recruitingPhase 32024-11-15NCT05993325